Elevated serum levels of high mobility group box 1 (HMGB1) protein in dengue-infected patients are associated with disease symptoms and secondary infection

Journal of Clinical Virology

Volumn 55, Issue 3, 2012, Pages 214-219

  Allonso, Diego ^a   Belgrano, Fabricio S ^a   Calzada, Naifi ^b   Guzmán, Maria G ^b   Vázquez, Susana ^b   Mohana Borges, Ronaldo ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b PAHO/WHO Collaborating Center for the Study of Dengue and its Vector   (Cuba)

Author keywords

Dengue pathogenesis; Dengue virus; HMGB1

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; DENGUE; DENGUE VIRUS; HMGB1 PROTEIN; HUMANS; SERUM; SEVERITY OF ILLNESS INDEX;

EID: 84866398727     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.07.010     Document Type: Article

References (37)

1. World Health Organization Dengue: guidelines for diagnosis, treatment prevention and control 2009, http://www.who.int/tdr/publications/training-guideline-publications/dengue-diagnosis-treatment/en/index.html.
2. Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010, 8:S7-S16.
3. Gubler D.J. Emerging vector-borne flavivirus diseases: are vaccines the solution?. Expert Rev Vaccines 2011, 10:563-565.
4. Guzman M.G., Kouri G. Dengue: an update. Lancet Infect Dis 2002, 2:33-42.
5. Harris E., Videa E., Perez L., Sandoval E., Tellez Y., Perez M.L., et al. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 2000, 63:5-11.
6. Chen L.C., Yeh T.M., Wu H.N., Lin Y.Y., Shyu H.W. Dengue virus infection induces passive release of high mobility group box 1 protein by epithelial cells. J Infect 2008, 56:143-150.
7. Kamau E., Takhampunya R., Li T., Kelly E., Peachman K.K., Lynch J.A., et al. Dengue virus infection promotes translocation of high mobility group box 1 protein from the nucleus to the cytosol in dendritic cells, upregulates cytokine production and modulates virus replication. J Gen Virol 2009, 90:1827-1835.
8. Bianchi M.E., Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr Opin Genet Dev 2005, 15:496-506.
9. Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta 2010, 1799:101-113.
10. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
11. Dumitriu I.E., Baruah P., Valentinis B., Voll R.E., Herrmann M., Nawroth P.P., et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005, 174:7506-7515.
12. Park J.S., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J.Y., Strassheim D., et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006, 290:C917-C924.
13. Sims G.P., Rowe D.C., Rietdijk S.T., Herbst R., Coyle A.J. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010, 28:367-388.
14. Urbonaviciute V., Furnrohr B.G., Meister S., Munoz L., Heyder P., De M.F., et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008, 205:3007-3018.
15. Yang R., Harada T., Mollen K.P., Prince J.M., Levy R.M., Englert J.A., et al. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med 2006, 12:105-114.
16. Sunden-Cullberg J., Norrby-Teglund A., Rouhiainen A., Rauvala H., Herman G., Tracey K.J., et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005, 33:564-573.
17. Taniguchi N., Kawahara K., Yone K., Hashiguchi T., Yamakuchi M., Goto M., et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003, 48:971-981.
18. Ito Y., Torii Y., Ohta R., Imai M., Hara S., Kawano Y., et al. Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children. Cytokine 2011, 56:180-187.
19. Nowak P., Barqasho B., Sonnerborg A. Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infection. AIDS 2007, 21:869-871.
20. Borde C., Barnay-Verdier S., Gaillard C., Hocini H., Marechal V., Gozlan J. Stepwise release of biologically active HMGB1 during HSV-2 infection. PLoS ONE 2011, 6:e16145.
21. Roche R.R., Alvarez M., Guzman M.G., Morier L., Kouri G. Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. J Clin Microbiol 2000, 38:3508-3510.
22. Rosario D., Alvarez M., Diaz J., Contreras R., Rodriguez R., Vazquez S., et al. Polymerase chain reaction for rapid detection and serotyping of dengue virus in clinical samples. Rev Panam Salud Publica 1998, 4:1-5.
23. Vazquez S., Perez A.B., Ruiz D., Rodriguez R., Pupo M., Calzada N., et al. Serological markers during dengue 3 primary and secondary infections. J Clin Virol 2005, 33:132-137.
24. Vazquez Y., Pupo-Antunez M., Vazquez S.V., Capo V., Torres G., Caballero Y., et al. Monoclonal antibody to dengue capsid protein: its application in dengue studies. MAbs 2009, 1:157-162.
25. Allonso D., Rosa M.S., Coelho D.R., Costa S.M., Nogueira R.M., Bozza F.B., et al. Properly folded Dengue virus NS1 protein expressed in E. coli generates polyclonal antibodies that enable sensitive and early dengue diagnosis. J Virol Methods 2011, 175:109-116.
26. Srikiatkhachorn A., Green S. Markers of dengue disease severity. Curr Top Microbiol Immunol 2010, 338:67-82.
27. Yang H., Tracey K.J. Targeting HMGB1 in inflammation. Biochim Biophys Acta 2010, 1799:149-156.
28. Oppenheim J.J., Tewary P., de la R.G., Yang D. Alarmins initiate host defense. Adv Exp Med Biol 2007, 601:185-194.
29. Moh A., Iwamoto Y., Chai G.X., Zhang S.S., Kano A., Yang D.D., et al. Role of STAT3 in liver regeneration: survival. DNA synthesis, inflammatory reaction and liver mass recovery. Lab Invest 2007, 87:1018-1028.
30. Craig D.G., Lee P., Pryde E.A., Masterton G.S., Hayes P.C., Simpson K.J. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int 2011, 31:1127-1136.
31. Zhou R.R., Zhao S.S., Zou M.X., Zhang P., Zhang B.X., Dai X.H., et al. HMGB1 cytoplasmic translocation in patients with acute liver failure. BMC Gastroenterol 2011, 11:21.
32. Troseid M., Nowak P., Nystrom J., Lindkvist A., Abdurahman S., Sonnerborg A. Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy. AIDS 2010, 24:1733-1737.
33. Chu J.J., Ng M.L. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J Gen Virol 2003, 84:3305-3314.
34. Mongkolsapaya J., Dejnirattisai W., Xu X.N., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003, 9:921-927.
35. Rothman A.L. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 2011, 11:532-543.
36. Halstead S.B., O'Rourke E.J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977, 265:739-741.
37. Halstead S.B., O'Rourke E.J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 1977, 146:201-217.